After six months of market share gains, CEO Søren Nielsen sees the VA as one of Demant’s biggest growth opportunities, but acknowledges that Sonova is still ahead.
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change — this is a corporate market-strategy announcement with no implications for clinical practice.
Competition between major manufacturers for the VA contract shapes which hearing aids are most accessible to the large and high-need veteran population, potentially influencing device availability and pricing across the sector.
- 01Demant CEO Søren Nielsen publicly targets the U.S. VA hearing-aid market as a priority growth area.
- 02Demant reports market share gains in the VA channel over the past six months.
- 03Sonova is acknowledged as the current market leader in VA hearing-aid supply.
- 04The VA represents one of the largest single institutional buyers of hearing aids in the world.
- 05Increased manufacturer competition in the VA channel could affect device selection and contract pricing.
Demant has gained market share in the U.S. VA hearing-aid market over the past six months.
quoteunclearSonova currently holds a leading position in the U.S. VA hearing-aid market.
quotepartially supported